zintick

ADMA Biologics ADMA

Adma Biologics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$13.21+26.05%close on Nov. 5, 2026 · volume 15.0M · Yahoo Finance

Price, last 53 sessions

$10.00$12.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 5, 2026 · high $13.21 · low $8.61 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Nov. 5, 2026Adam S. Grossman
President and CEO, director
Sold
10b5-1 plan
147,000$12.00$1.76 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 7 →
  • 4Nov. 5, 2026, 9:05 p.m. ETView on SEC.gov
  • 10-QNov. 4, 2026, 5:16 p.m. ETView on SEC.gov
  • 8-KNov. 4, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedADMA Biologics Q3 2026 adjusted EPS $0.23 beats $0.20 consensus on $141.1 million revenue; FY2026 revenue floor of $530 million sits below $535.3 million consensus

  • SCHEDULE 13GAug. 7, 2026, 8:23 a.m. ETView on SEC.gov
  • 10-QAug. 5, 2026, 5:16 p.m. ETView on SEC.gov
  • 8-KAug. 5, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • 4July 28, 2026, 9 p.m. ETView on SEC.gov